Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.43 - $5.9 $516 - $7,080
1,200 Added 0.08%
1,480,419 $856,000
Q2 2022

Aug 01, 2022

BUY
$0.38 - $0.64 $9,500 - $16,000
25,000 Added 1.72%
1,479,219 $707,000
Q1 2022

May 09, 2022

BUY
$0.55 - $0.98 $29,242 - $52,104
53,168 Added 3.79%
1,454,219 $974,000
Q4 2021

Feb 08, 2022

BUY
$0.9 - $1.31 $66,282 - $96,477
73,647 Added 5.55%
1,401,051 $1.38 Million
Q3 2021

Nov 12, 2021

SELL
$1.21 - $1.61 $1,092 - $1,453
-903 Reduced 0.07%
1,327,404 $1.7 Million
Q2 2021

Jul 28, 2021

SELL
$1.6 - $2.02 $24,796 - $31,305
-15,498 Reduced 1.15%
1,328,307 $2.17 Million
Q1 2021

May 14, 2021

SELL
$1.86 - $2.87 $3,411 - $5,263
-1,834 Reduced 0.14%
1,343,805 $2.66 Million
Q4 2020

Feb 12, 2021

BUY
$1.65 - $2.43 $551,771 - $812,609
334,407 Added 33.07%
1,345,639 $2.79 Million
Q3 2020

Nov 12, 2020

SELL
$1.6 - $2.35 $316 - $465
-198 Reduced 0.02%
1,011,232 $1.73 Million
Q2 2020

Aug 13, 2020

SELL
$1.33 - $2.76 $131,173 - $272,210
-98,627 Reduced 8.88%
1,011,430 $2.35 Million
Q1 2020

May 11, 2020

SELL
$0.97 - $2.85 $53,402 - $156,903
-55,054 Reduced 4.73%
1,110,057 $1.72 Million
Q4 2019

Feb 14, 2020

SELL
$1.69 - $3.8 $96,095 - $216,071
-56,861 Reduced 4.65%
1,165,111 $4.43 Million
Q3 2019

Nov 08, 2019

SELL
$0.61 - $2.21 $281,950 - $1.02 Million
-462,214 Reduced 27.44%
1,221,972 $2.25 Million
Q2 2019

Aug 12, 2019

BUY
$0.51 - $0.86 $157,920 - $266,297
309,648 Added 22.53%
1,684,186 $1.1 Million
Q1 2019

May 13, 2019

BUY
$0.51 - $0.82 $44,473 - $71,505
87,202 Added 6.77%
1,374,538 $860,000
Q4 2018

Jan 18, 2019

SELL
$0.48 - $1.1 $580,030 - $1.33 Million
-1,208,397 Reduced 48.42%
1,287,336 $622,000
Q3 2018

Nov 13, 2018

BUY
$1.06 - $1.69 $1.07 Million - $1.71 Million
1,012,698 Added 68.29%
2,495,733 $2.75 Million
Q2 2018

Aug 09, 2018

BUY
$1.56 - $2.51 $556,735 - $895,773
356,882 Added 31.69%
1,483,035 $2.31 Million
Q1 2018

May 09, 2018

SELL
$0.91 - $2.24 $9,863 - $24,279
-10,839 Reduced 0.95%
1,126,153 $2.41 Million
Q4 2017

Feb 13, 2018

SELL
$0.78 - $2.1 $87,126 - $234,572
-111,701 Reduced 8.95%
1,136,992 $1.05 Million
Q3 2017

Nov 14, 2017

BUY
$1.55 - $1.82 $1.94 Million - $2.27 Million
1,248,693
1,248,693 $2.21 Million

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $171M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Gagnon Securities LLC Portfolio

Follow Gagnon Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gagnon Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gagnon Securities LLC with notifications on news.